Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease. Gabriels RY, van der Waaij AM, Linssen MD, Dobosz M, et al. Gut 2024 Apr 5:gutjnl-2023-331696. doi: 10.1136/gutjnl-2023-331696.

Read + Share

Amedeo Smart

Independent Medical Education

Gabriels RY, van der Waaij AM, Linssen MD, Dobosz M, et al. Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease. Gut 2024 Apr 5:gutjnl-2023-331696. doi: 10.1136/gutjnl-2023-331696.
PMID: 38580386